NIH-funded research U01 cooperative agreement

Chronic Pancreatitis and Related Conditions Data Center Supports Multi-Center Research

Official title: Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC)

Funded at University of Tx Md Anderson Can Ctr · NIH-11592146 · Data updated 2026-11-12

A national effort to organize and share clinical data and biosamples from people with chronic pancreatitis, pancreatogenic diabetes, and pancreatic cancer to speed biomarker discovery and new treatments.

More Pancreatitis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 28, 2015
Project endJune 30, 2030
Funding year2026
Award (this year)$802,445
NIH project number3U01DK108328-12S1
Project IDNIH-11592146 on NIH RePORTER

Who could benefit from this research

Could help

Adults with chronic pancreatitis, pancreatogenic diabetes, or related pancreatic conditions who participate in consortium studies and provide consent for data and biospecimen sharing.

Less likely to help

Some individuals may not directly benefit if their care decisions are not changed by the research findings or if they do not participate in the data/biospecimen programs.

What this research studies

This grant funds the Data Coordinating Center for a long-running, nationwide research consortium focused on chronic pancreatitis, pancreatogenic diabetes, and pancreatic cancer. It supports standardized data collection, biospecimen handling, and data sharing across multiple sites to create a coherent picture of disease progression and outcomes. By coordinating clinical measures, biological samples, and analytical tools, it aims to uncover biomarkers and test new therapeutic approaches that could benefit patients with exocrine pancreatic diseases. Participation would involve contributing data and samples through coordinated studies like PROCEED, INSPPIRE 2, NOD, and DETECT, under rigorous governance and quality controls. The effort is designed to enable future translational research and improve patient care pathways across diverse centers.

Why it matters

Potential benefit: Could accelerate discovery of biomarkers and therapies that improve diagnosis, prognosis, and treatment for CP, pancreatogenic diabetes, and PDAC.

How similar studies have gone: Previous consortium efforts have enabled multicenter studies and data harmonization that advanced understanding of CP and related conditions.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Li, Liang — University of Tx Md Anderson Can Ctr
  • Study coordinator: Li, Liang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.